文献速递外周动脉疾病

下肢外周动脉疾病血运重建的预测因素:PORTRAIT研究的启示

Predictors of Revascularization in Lower-Extremity Peripheral Artery Disease: Insights From the PORTRAIT Study.
PubMed 文献 · J Endovasc Ther · 2023-06-13

PORTRAIT研究纳入2011年6月至2015年9月10个中心的797例新发或加重的外周动脉疾病患者,28.1%在就诊3个月内接受早期血运重建。Rutherford 3级和同时累及髂股及膝下动脉病变与更高血运重建几率相关,而病程>12个月、较高踝肱指数和较高外周动脉问卷评分与更低几率相关。不同中心血运重建率从6.25%到66.28%不等,中位OR为1.88(95%CI 1.38-3.57)。

要点

  • 797例症状性外周动脉疾病患者中224例(28.1%)在3个月内接受早期血运重建。
  • Rutherford 3级(vs 1级;OR=1.86,95%CI 1.04-3.33)与更高血运重建几率相关。
  • 不同中心血运重建率6.25%至66.28%,中位OR=1.88(95%CI 1.38-3.57)。

核心结论

  • 约三分之一症状性外周动脉疾病患者接受早期血运重建,更广泛的病变和症状负担是主要预测因素。
  • 不同中心血运重建模式存在显著差异,需进一步研究以了解差异来源和最佳选择标准。

研究设计与样本

  • PORTRAIT研究为10个中心、2011年6月至2015年9月入组的新发或近期加重外周动脉疾病患者,共797例。
  • 早期血运重建定义为就诊3个月内进行的血管内或外科手术。
  • 采用分层逻辑回归识别与早期血运重建相关的患者特征,并用中位OR评估中心间变异。

主要发现

  • 797例中224例(28.1%)接受早期血运重建。
  • Rutherford 3级(vs Rutherford 1级;OR=1.86,95%CI 1.04-3.33)与更高血运重建几率相关。
  • 髂股及膝下动脉均存在病变(vs 仅膝下;OR=1.75,95%CI 1.15-2.67)与更高血运重建几率相关。
  • 外周动脉疾病病程>12个月(vs 1-6个月;OR=0.50,95%CI 0.32-0.77)与更低血运重建几率相关。
  • 踝肱指数每增加0.1单位(OR=0.86,95%CI 0.78-0.96)和外周动脉问卷总结评分每增加10单位(OR=0.89,95%CI 0.80-0.99)与更低血运重建几率相关。

关键数值与推荐

  • 指南推荐仅对生活方式受限且对目标导向药物治疗无效的跛行患者进行血运重建(class IIA,level of evidence A)。
  • 不同中心血运重建原始率范围为6.25%至66.28%,中位OR=1.88(95%CI 1.38-3.57)。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Peripheral artery disease (PAD) guidelines recommend revascularization only for patients with lifestyle-limiting claudication that is refractory to goal-directed medical therapy (class IIA, level of evidence A). However, real-world invasive treatment patterns and predictors of revascularization in patients with symptomatic lower-extremity PAD are still largely unknown. AIM: We aimed to examine rates, patient-level predictors, and site variability of early revascularization in patients with new or worsening PAD symptoms. METHODS: Among patients with new-onset or recent exacerbation of PAD in the 10-center Patient-centered Outcomes Related to TReatment practices in peripheral Arterial disease: Investigating Trajectories (PORTRAIT) study enrolled between June 2011 and September 2015, we classified early revascularization (endovascular or surgical) as procedures being performed within 3 months of presentation. Hierarchical logistic regression was used to identify patient characteristics associated with early revascularization. Variability across sites was estimated using the median odds ratio (OR). RESULTS: Among 797 participants, early revascularization procedures were performed in 224 (28.1%). Rutherford class 3 (vs Rutherford class 1; OR=1.86, 95% confidence interval [CI] 1.04-3.33) and having lesions in both iliofemoral and below-the-knee arterial segments (vs below the knee only; OR=1.75, 95% CI: 1.15-2.67) were associated with a higher odds of revascularization. Longer PAD duration >12 months (vs 1-6 months; OR=0.50, 95% CI: 0.32-0.77), higher ankle-brachial index scores (per 0.1 unit increase; OR=0.86, 95% CI: 0.78-0.96), and higher Peripheral Artery Questionnaire Summary scores (per 10 unit increase; OR=0.89, 95% CI: 0.80-0.99) were associated with a lower odds of revascularization. The raw rates for revascularization in different sites ranged from 6.25% to 66.28%, and the median OR was 1.88, 95% CI: 1.38-3.57. CONCLUSIONS: About 1 in 3 patients with symptomatic PAD received early revascularization. A more extensive disease and symptom burden were the main predictors of receiving early revascularization in PAD. There was significant site variability in revascularization patterns, and further studies will better understand the source of this variability and optimal selection criteria for early revascularization.Clinical ImpactReal world patterns and predictors of early revascularization in peripheral artery disease are not well understood. In this retrospective analysis of the POTRAIT study, about 1 out of 3 patients with PAD symptoms received early revascularization, with significant site variability. A more extensive disease and symptom burden were the main predictors of receiving early revascularization in PAD.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Pokharel Y, Kokkinidis DG, Wang J, et al. Predictors of Revascularization in Lower-Extremity Peripheral Artery Disease: Insights From the PORTRAIT Study. J Endovasc Ther. 2023. PMID: 37309164. doi:10.1177/15266028231179574

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。